Develops a pill for ulcerative colitis, a painful gut disease.
New: first time
Melqart bought Abivax for the first time between April and June: 307,250 shares, worth about $41 million. That’s already $4 of every $100 they have in stocks.
Mar 31
None
Jun 30
307,250
The numbers
Shares they own
307,250
Value on Jun 30, 2026
$40,944,135
about $41 million
Share of their money
3.9%
$4 of every $100 · 8th of 40
Price per share on Jun 30
$133.26
Kind
Shares
More about Abivax ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.